United States · Platforms & data · MarketBeat

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

Published by MarketBeat · United States 1 h ago

Wells Fargo & Company lifted their target price on Vertex Pharmaceuticals from $550.00 to $650.00 and gave the company an "overweight" rating in a research note on Tuesday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

MarketWatch

Want to help your adult kids and grandkids? Give them money while you’re still alive.

The Motley Fool

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00

Share

Also worth reading

Renew outlines FY2027 adjusted EBITDA guidance of INR 105B to INR 109B as take-private process targets Q1 2027 close

Want to help your adult kids and grandkids? Give them money while you’re still alive.

Where Will QuantumScape Stock Be in 5 Years?

Regal Rexnord Q3 2026 slides: organic growth accelerates to 6.1%

Stock market after midterm elections: What S&P 500 history shows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030